|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 409/14 | |||
| A61K 31/517 | |||
| A61P 25/16 | |||
| A61P 25/18 |
| (11) | Number of the document | 2346848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09744414.5 |
| Date of filing the European patent application | 2009-11-04 | |
| (97) | Date of publication of the European application | 2011-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/064604 |
| Date | 2009-11-04 |
| (87) | Number | WO 2010/054968 |
| Date | 2010-05-20 |
| (30) | Number | Date | Country code |
| 08169162 | 2008-11-14 | EP |
| (72) |
KNUST, Henner, DE
LIMBERG, Anja, CH
NETTEKOVEN, Matthias, DE
RATNI, Hasane, FR
RIEMER, Claus, DE
VIFIAN, Walter, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS |
| QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS |